FBLG
FibroBiologics, Inc. Common Stock
NASDAQ: FBLG · HEALTHCARE · BIOTECHNOLOGY
$1.32
+0.76% today
Updated 2026-04-30
Market cap
$6.45M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-8.40
Dividend yield
—
52W range
$1 – $23
Volume
1.0M
FibroBiologics, Inc. Common Stock (FBLG) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — |
| Cost of revenue | — | — | $94000.00 | $437000.00 | $573000.00 |
| Gross profit | — | — | $-94000.00 | $-437000.00 | $-573000.00 |
| Gross margin | — | — | — | — | — |
| R&D | $669000.00 | $521000.00 | $1.15M | $2.37M | $4.50M |
| SG&A | $500000.00 | $1.06M | $3.32M | $6.52M | $9.23M |
| Operating income | $-1.17M | $-1.58M | $-4.47M | $-8.89M | $-13.74M |
| Operating margin | — | — | — | — | — |
| EBITDA | — | $-1.58M | $-4.37M | $-15.90M | $-10.57M |
| EBITDA margin | — | — | — | — | — |
| EBIT | — | — | $-4.47M | $-16.34M | $-11.14M |
| Interest expense | — | $4000.00 | $654000.00 | $147000.00 | $20000.00 |
| Income tax | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-1.17M | $-1.58M | $-5.12M | $-16.48M | $-11.16M |
| Net income growth (YoY) | — | -35.3% | -223.7% | -221.9% | +32.3% |
| Profit margin | — | — | — | — | — |